133 related articles for article (PubMed ID: 7414016)
21. [Tomographic diagnosis of adrenal disorders: comparative study of adrenal scintigraphy and x-ray computed tomography (author's transl)].
Fukunaga M; Nakano Y; Morita R; Shigeno C; Dodo Y; Harioka T; Dokoh S; Yamamoto I; Fujita T; Torizuka K; Inoue A; Tanimura H; Kawamura J
Kaku Igaku; 1980 Aug; 17(7):857-62. PubMed ID: 7441931
[No Abstract] [Full Text] [Related]
22. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
[No Abstract] [Full Text] [Related]
23. A comparison of 19-iodocholesterol-131I with 6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol-131I as an adrenal-scanning agent.
Nitta K; Ogawa H; Ito T; Kojima M; Maeda M
Chem Pharm Bull (Tokyo); 1976 Oct; 24(10):2322-6. PubMed ID: 1017078
[No Abstract] [Full Text] [Related]
24. [Effects of specific radioactivities and cholagogues on tissue distribution of 131I-6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-131I) in rats].
Ito T; Ogawa H; Maeda M; Kojima M
Yakugaku Zasshi; 1983 Jun; 103(6):644-9. PubMed ID: 6655551
[No Abstract] [Full Text] [Related]
25. [New adrenal scintiscanning agents. Comparative study of 66beta-iodomethyl-19-nor-cholest-5(10)-en-3 beta-ol-125I and 19-iodocholesterol-125I].
Umeda F; Kato K; Ibayashi H; Maeda M; Kojima M
Kaku Igaku; 1977 Jun; 14(3):335-40. PubMed ID: 916369
[No Abstract] [Full Text] [Related]
26. Adrenal imaging with radioiodocholesterol. Review of the University of Wisconsin Hospital experience.
Kasner JR; Lieberman LM
Wis Med J; 1977 Dec; 76(12):S 152-4. PubMed ID: 602244
[No Abstract] [Full Text] [Related]
27. Adrenal scintigraphy using 123I labeled 6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-123I).
Kamoi I; Oshiumi Y; Tateno Y; Shishido F; Ido T; Suzuki K; Irie T; Fukushi K; Nakayama C; Matsuura K; Itoh T; Ogawa H; Maeda M; Kojima M
Kaku Igaku; 1980 May; 17(4):389-93. PubMed ID: 7401398
[No Abstract] [Full Text] [Related]
28. Comparison of 19-lodocholesterol and 6-lodomethylnorcholesterol as adrenal-scanning agents.
Couch MW; Williams CM
J Nucl Med; 1977 Jul; 18(7):724-7. PubMed ID: 874152
[TBL] [Abstract][Full Text] [Related]
29. [Studies on adrenal scanning agents, 131I-adosterol (author's transl)].
Yonahara Y; Takahara Y; Sasaki Y; Kirimura H; Sato A
Radioisotopes; 1977 Feb; 26(2):102-5. PubMed ID: 577028
[No Abstract] [Full Text] [Related]
30. Adrenal imaging with 131I-adosterol (NCL-6-131I) by diverging and pinhole methods. II. Analysis of abnormal adrenal images.
Nakajo M
Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Feb; 42(2):160-87. PubMed ID: 7110924
[No Abstract] [Full Text] [Related]
31. Synthesis and evaluation of 24-(isopropyl[75Se]seleno)chol-5-en-3 beta-ol.
Knapp FF; Butler TA; Ferren LA; Callahan AP; Guyer CE; Coffey JL
J Med Chem; 1983 Oct; 26(10):1538-41. PubMed ID: 6620312
[TBL] [Abstract][Full Text] [Related]
32. [Assessment of retroperitoneal pneumography in the diagnosis of adrenal diseases (author's transl)].
Chen XR
Zhonghua Fang She Xue Za Zhi; 1980 Aug; 14(3):191-4. PubMed ID: 6451406
[No Abstract] [Full Text] [Related]
33. Clinical experience with 75Se selenomethylcholesterol adrenal imaging.
Shapiro B; Britton KE; Hawkins LA; Edwards CR
Clin Endocrinol (Oxf); 1981 Jul; 15(1):19-27. PubMed ID: 7307282
[TBL] [Abstract][Full Text] [Related]
34. [Computed tomography of the adrenal glands (author's transl)].
Divano L; Osteaux M; Peetrons P; Jeanmart L
Rev Med Brux; 1980 Dec; 1(10):651-9. PubMed ID: 7209189
[No Abstract] [Full Text] [Related]
35. [Radionuclide picture of adrenal glands].
Tajfl DF
Srp Arh Celok Lek; 1980 Dec; 108(12):1295-1304. PubMed ID: 7313838
[No Abstract] [Full Text] [Related]
36. Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol.
Ryo UY; Johnston AS; Kim I; Pinsky SM
Radiology; 1978 Jul; 128(1):157-61. PubMed ID: 663202
[TBL] [Abstract][Full Text] [Related]
37. Chemical and radiochemical stability of the adrenal-scanning agents, 6beta-iodomethyl-19-norcholest-5(10-en-3beta-ol and 19-iodocholest-5-en-3beta-ol.
Scott KN; Mareci TH; Couch MW; Williams CM
Steroids; 1977 Oct; 30(4):511-9. PubMed ID: 605458
[TBL] [Abstract][Full Text] [Related]
38. [Scintigraphic exploration of the adrenal glands using I-131-6 beta iodomethyl-19-norcholesterol. A practical guide].
Kraimps JL; Bardet S; Nocaudie-Calzada M; Tabarin A; Wémeau JL
Ann Chir; 1999; 53(3):255-60. PubMed ID: 10339872
[No Abstract] [Full Text] [Related]
39. Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Reschini E; Catania A
Eur J Nucl Med; 1991; 18(10):817-23. PubMed ID: 1743205
[TBL] [Abstract][Full Text] [Related]
40. Selenium-75-19-selenocholesterol-a new adrenal scanning agent with high concentration in the adrenal medulla.
Sarkar SD; Ice RD; Beierwaltes WH; Gill SP; Balachandran S; Basmadjian GP
J Nucl Med; 1976 Mar; 17(3):212-7. PubMed ID: 1249631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
